Advertisement

The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson’s disease patients

  • Ioannis E. DagklisEmail author
  • Efthymia Tsantaki
  • Dimitrios Kazis
  • Varvara Theodoridou
  • Sotirios Papagiannopoulos
  • Dimitrios Ntantos
  • Sevasti Bostantjopoulou
Original Article
  • 23 Downloads

Abstract

Objective

Fatigue is one of the most frequent and important nonmotor symptoms of patients with Parkinson disease (PD), affecting quality of life. Although, in some cases, it may be a severe and debilitating complaint, it remains relatively unexplored. The PFS-16 is a fatigue measure, specifically designed for PD patients. The aim of this study was to investigate the psychometric properties of Parkinson fatigue scale (PFS-16) in Greek PD patients.

Methods

In total, 99 patients with PD were assessed. The following psychometric properties were tested: data quality, floor/ceiling effects, reliability (internal consistency, test–retest reliability), and construct validity. Construct validity was evaluated by examining correlations with other variables including other fatigue measures such as Fatigue Severity Scale (FSS) and the vitality scale (SF-VT) of SF-36. Moreover, assumptions were explored about “known” groups concerning fatigue.

Results

The mean score for the PFS-16 was 2.95 (± 0.91); acceptability was good with negligible floor and ceiling effects. Results showed high internal consistency (Cronbach’s alpha, 0.96) and test–retest reliability (ICC, 0.93). Strong correlations were observed between the PFS-16 and other fatigue (FFS and SF-VT) measures (rs = 0.77 and − 0.70, p < 0.001), revealing appropriate validity. Furthermore, predictions for “known” groups validity were verified.

Conclusion

The Greek version of the PFS-16 showed satisfactory reliability and validity and thus can be regarded as a useful tool in assessing fatigue in PD.

Keywords

Fatigue Parkinson fatigue scale Reliability Validity 

Notes

Acknowledgements

We gratefully thank Prof. Brown for his permission to translate and use the PFS-16 in this study and for his useful remarks.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Compliance with ethical standards

The study was carried out in accordance with the Declaration of Helsinki on Ethical Principles for Medical Research.

Conflicting interests

The authors declare that they have no conflict of interest.

References

  1. 1.
    Pfeiffer RF (2016) Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):S119–S122CrossRefGoogle Scholar
  2. 2.
    Metta V, et al. (2011) The possible clinical predictors of fatigue in Parkinson’s disease: a study of 135 patients as part of international nonmotor scale validation project. Parkinsons Dis, 2011. p. 125271Google Scholar
  3. 3.
    Goldman JG, Stebbins GT, Leung V, Tilley BC, Goetz CG (2014) Relationships among cognitive impairment, sleep, and fatigue in Parkinson’s disease using the MDS-UPDRS. Parkinsonism Relat Disord 20(11):1135–1139CrossRefGoogle Scholar
  4. 4.
    Kluger BM, Herlofson K, Chou KL, Lou JS, Goetz CG, Lang AE, Weintraub D, Friedman J (2016) Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord 31(5):625–631CrossRefGoogle Scholar
  5. 5.
    Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, Marsh L, Nail L, Shulman L, Taylor CB, Working Group on Fatigue in Parkinson's Disease (2007) Fatigue in Parkinson’s disease: a review. Mov Disord 22(3):297–308CrossRefGoogle Scholar
  6. 6.
    Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD, on behalf of the PRIAMO study group (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefGoogle Scholar
  7. 7.
    Karlsen K, Larsen JP, Tandberg E, Jørgensen K (1999) Fatigue in patients with Parkinson’s disease. Mov Disord 14(2):237–241CrossRefGoogle Scholar
  8. 8.
    Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, de Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Iannacone C, Zappia M, For the FORTE Study Group (2014) Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology 83(3):215–220CrossRefGoogle Scholar
  9. 9.
    Alves G, Wentzel-Larsen T, Larsen JP (2004) Is fatigue an independent and persistent symptom in patients with Parkinson disease? Neurology 63(10):1908–1911CrossRefGoogle Scholar
  10. 10.
    Friedman JH, Abrantes A, Sweet LH (2011) Fatigue in Parkinson’s disease. Expert Opin Pharmacother 12(13):1999–2007CrossRefGoogle Scholar
  11. 11.
    Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363(9413):978–988CrossRefGoogle Scholar
  12. 12.
    Friedman JH et al (2016) Fatigue in Parkinson’s disease: report from a mutidisciplinary symposium. NPJ Parkinsons Dis 2Google Scholar
  13. 13.
    Brown RG, Dittner A, Findley L, Wessely SC (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11(1):49–55CrossRefGoogle Scholar
  14. 14.
    Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins G, Schrag A (2010) Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson’s disease. Mov Disord 25(7):805–822CrossRefGoogle Scholar
  15. 15.
    Kummer A, Scalzo P, Cardoso F, Teixeira AL (2011) Evaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale. Acta Neurol Scand 123(2):130–136CrossRefGoogle Scholar
  16. 16.
    Hagell P, Rosblom T, Palhagen S (2012) A Swedish version of the 16-item Parkinson fatigue scale (PFS-16). Acta Neurol Scand 125(4):288–292CrossRefGoogle Scholar
  17. 17.
    Fu R, Cui SS, du JJ, Huang P, He YC, Gao C, Luo XG, Chen SD (2017) Validation of the Parkinson Fatigue Scale in Chinese Parkinson’s disease patients. Brain Behav 7(6):e00712CrossRefGoogle Scholar
  18. 18.
    Ozturk EA, Kocer BG, Umay E, Cakci A (2018) Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale. Qual Life Res 27:2719–2730CrossRefGoogle Scholar
  19. 19.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefGoogle Scholar
  20. 20.
    Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRefGoogle Scholar
  21. 21.
    Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 8(2):94–104CrossRefGoogle Scholar
  22. 22.
    Nilsson MH, Bladh S, Hagell P (2013) Fatigue in Parkinson’s disease: measurement properties of a generic and a condition-specific rating scale. J Pain Symptom Manag 46(5):737–746CrossRefGoogle Scholar
  23. 23.
    Krupp LB, LaRocca N, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123CrossRefGoogle Scholar
  24. 24.
    Katsarou Z et al (2007) Immune factors or depression? Fatigue correlates in Parkinson’s disease. Rev Neurol 45(12):725–728PubMedGoogle Scholar
  25. 25.
    Hadjimichael O, Vollmer T, Oleen-Burkey M (2008) Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 6:100CrossRefGoogle Scholar
  26. 26.
    Bakalidou D, Skordilis EK, Giannopoulos S, Stamboulis E, Voumvourakis K (2013) Validity and reliability of the FSS in Greek MS patients. Springerplus 2(1):304CrossRefGoogle Scholar
  27. 27.
    Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefGoogle Scholar
  28. 28.
    Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22(1):41–47CrossRefGoogle Scholar
  29. 29.
    Cohen, J., Statistical power analysis for the behavioral sciences. 2nd ed. ed. 1988, Hillsdale, N.J.: L. Erlbaum AssociatesGoogle Scholar
  30. 30.
    McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293–307CrossRefGoogle Scholar
  31. 31.
    Nunnally, J.C. and I.H. Bernstein, Psychometric theory. 3rd ed. ed. 1994, New York ; London: McGraw-HillGoogle Scholar
  32. 32.
    Streiner, D.L. and G.R. Norman, Health measurement scales: a practical guide to their development and use. 4th ed. ed. 2008, Oxford: Oxford University PressGoogle Scholar
  33. 33.
    Bowling A (2009) Research methods in health: investigating health and health services. 3rd ed. ed. Maidenhead: Open University PressGoogle Scholar
  34. 34.
    Solla P, Cannas A, Mulas CS, Perra S, Corona A, Bassareo PP, Marrosu F (2014) Association between fatigue and other motor and non-motor symptoms in Parkinson’s disease patients. J Neurol 261(2):382–391CrossRefGoogle Scholar
  35. 35.
    Fu R, Luo XG, Ren Y, He ZY, Lv H (2016) Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment. Transl Neurodegener 5:9CrossRefGoogle Scholar
  36. 36.
    Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80(9):800–809CrossRefGoogle Scholar
  37. 37.
    Franke C, Storch A (2017) Nonmotor fluctuations in Parkinson’s disease. Int Rev Neurobiol 134:947–971CrossRefGoogle Scholar
  38. 38.
    Grace J, Mendelsohn A, Friedman JH (2007) A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat Disord 13(7):443–445CrossRefGoogle Scholar
  39. 39.
    Okuma Y, Kamei S, Morita A, Yoshii F, Yamamoto T, Hashimoto S, Utsumi H, Hatano T, Hattori N, Matsumura M, Takahashi K, Nogawa S, Watanabe Y, Miyamoto T, Miyamoto M, Hirata K (2009) Fatigue in Japanese patients with Parkinson’s disease: a study using Parkinson fatigue scale. Mov Disord 24(13):1977–1983CrossRefGoogle Scholar
  40. 40.
    Skorvanek M, Gdovinova Z, Rosenberger J, Ghorbani Saeedian R, Nagyova I, Groothoff JW, van Dijk JP (2015) The associations between fatigue, apathy, and depression in Parkinson’s disease. Acta Neurol Scand 131(2):80–87CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  • Ioannis E. Dagklis
    • 1
    Email author return OK on get
  • Efthymia Tsantaki
    • 2
  • Dimitrios Kazis
    • 1
  • Varvara Theodoridou
    • 1
  • Sotirios Papagiannopoulos
    • 1
  • Dimitrios Ntantos
    • 1
  • Sevasti Bostantjopoulou
    • 1
  1. 1.3rd Department of NeurologyAristotle University of Thessaloniki, G. Papanikolaou HospitalThessalonikiGreece
  2. 2.Laboratory of Primary Health Care, General Practice and Health Services Research - Medical SchoolAristotle University of ThessalonikiThessalonikiGreece

Personalised recommendations